Source: The Business Journals: Greensboro/Winston-Salem/High Point

Genomic Health: Exact Sciences completes $2.8B acquisition of Genomic Health

Exact Sciences Corp., the Madison-based maker of the Cologuard take-home colon cancer test and one of the largest public companies in Wisconsin, has completed its $2.8 billion acquisition deal of California's Genomic Health, the company said Friday. The combined companies will generate revenue of about $1.6 billion in 2020 and have a commercial presence in more than 90 countries with a cancer test portfolio that reaches across primary care, oncology, OB/GYN, gastroenterology and urology. With...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Estimated Annual Revenue

Estimated Employees

CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Genomic Health is a biotechnology company that provides genomic-based diagnostic test services to the treatment of early... Read more